{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T06:10:09Z","timestamp":1751782209391,"version":"3.41.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12265-018-9819-8","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T18:27:28Z","timestamp":1533234448000},"page":"310-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mirabegron, a Clinically Approved \u03b23 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction"],"prefix":"10.1007","volume":"11","author":[{"given":"Xavier","family":"Rossello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Fern\u00e1ndez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Gal\u00e1n-Arriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Lobo-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Paul","family":"Vilchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Garc\u00eda-Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Manuel","family":"Garc\u00eda-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Garc\u00eda-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sanz-Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"9819_CR1","doi-asserted-by":"publisher","unstructured":"Rossell\u00f3, X., Huo, Y., Pocock, S., Van de Werf, F., Chin, C. T., Danchin, N., \u2026 Bueno, H. (2017). Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality. International Journal of Cardiology, 245, 27\u201334. https:\/\/doi.org\/10.1016\/j.ijcard.2017.07.039 .","DOI":"10.1016\/j.ijcard.2017.07.039"},{"issue":"42","key":"9819_CR2","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","volume":"37","author":"N Townsend","year":"2016","unstructured":"Townsend, N., Wilson, L., Bhatnagar, P., Wickramasinghe, K., Rayner, M., & Nichols, M. (2016). Cardiovascular disease in Europe: epidemiological update 2016. European Heart Journal, 37(42), 3232\u20133245. https:\/\/doi.org\/10.1093\/eurheartj\/ehw334 .","journal-title":"European Heart Journal"},{"key":"9819_CR3","doi-asserted-by":"publisher","unstructured":"Stone, G. W., Selker, H. P., Thiele, H., Patel, M. R., Udelson, J. E., Ohman, E. M., \u2026 Ben-Yehuda, O. (2016). Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. Journal of the American College of Cardiology, 67(14), 1674\u201383. https:\/\/doi.org\/10.1016\/j.jacc.2016.01.069 .","DOI":"10.1016\/j.jacc.2016.01.069"},{"issue":"14","key":"9819_CR4","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","volume":"65","author":"B Ib\u00e1\u00f1ez","year":"2015","unstructured":"Ib\u00e1\u00f1ez, B., Heusch, G., Ovize, M., & Van de Werf, F. (2015). Evolving therapies for myocardial ischemia\/reperfusion injury. Journal of the American College of Cardiology, 65(14), 1454\u20131471. https:\/\/doi.org\/10.1016\/j.jacc.2015.02.032 .","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"9819_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrcardio.2014.137","volume":"11","author":"V Fuster","year":"2014","unstructured":"Fuster, V. (2014). Top 10 cardiovascular therapies and interventions for the next decade. Nature Reviews. Cardiology, 11(11), 671\u2013683. https:\/\/doi.org\/10.1038\/nrcardio.2014.137 .","journal-title":"Nature Reviews. Cardiology"},{"issue":"2","key":"9819_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1172\/JCI118823","volume":"98","author":"C Gauthier","year":"1996","unstructured":"Gauthier, C., Tavernier, G., Charpentier, F., Langin, D., & Le Marec, H. (1996). Functional beta3-adrenoceptor in the human heart. The Journal of Clinical Investigation, 98(2), 556\u2013562. https:\/\/doi.org\/10.1172\/JCI118823 .","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"9819_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/cvr\/cvw056","volume":"111","author":"J-L Balligand","year":"2016","unstructured":"Balligand, J.-L. (2016). Cardiac salvage by tweaking with beta-3-adrenergic receptors. Cardiovascular Research, 111(2), 128\u2013133. https:\/\/doi.org\/10.1093\/cvr\/cvw056 .","journal-title":"Cardiovascular Research"},{"key":"9819_CR8","doi-asserted-by":"publisher","unstructured":"Arag\u00f3n, J. P., Condit, M. E., Bhushan, S., Predmore, B. L., Patel, S. S., Grinsfelder, D. B., \u2026 Lefer, D. J. (2011). Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. Journal of the American College of Cardiology, 58(25), 2683\u201391. https:\/\/doi.org\/10.1016\/j.jacc.2011.09.033 .","DOI":"10.1016\/j.jacc.2011.09.033"},{"issue":"4","key":"9819_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00395-014-0422-0","volume":"109","author":"J Garc\u00eda-Prieto","year":"2014","unstructured":"Garc\u00eda-Prieto, J., Garc\u00eda-Ruiz, J. M., Sanz-Rosa, D., Pun, A., Garc\u00eda-Alvarez, A., Davidson, S. M., et al. (2014). \u03b23 adrenergic receptor selective stimulation during ischemia\/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. Basic Research in Cardiology, 109(4), 422. https:\/\/doi.org\/10.1007\/s00395-014-0422-0 .","journal-title":"Basic Research in Cardiology"},{"key":"9819_CR10","doi-asserted-by":"publisher","unstructured":"Niu, X., Zhao, L., Li, X., Xue, Y., Wang, B., Lv, Z., \u2026 Zheng, Q. (2014). \u03b23-Adrenoreceptor stimulation protects against myocardial infarction injury via eNOS and nNOS activation. PLoS One, 9(6), e98713. https:\/\/doi.org\/10.1371\/journal.pone.0098713 .","DOI":"10.1371\/journal.pone.0098713"},{"key":"9819_CR11","doi-asserted-by":"publisher","unstructured":"Niu, X., Watts, V. L., Cingolani, O. H., Sivakumaran, V., Leyton-Mange, J. S., Ellis, C. L., \u2026 Barouch, L. A. (2012). Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. Journal of the American College of Cardiology, 59(22), 1979\u201387. https:\/\/doi.org\/10.1016\/j.jacc.2011.12.046 .","DOI":"10.1016\/j.jacc.2011.12.046"},{"key":"9819_CR12","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-\u00c1lvarez, A., Pereda, D., Garc\u00eda-Lunar, I., Sanz-Rosa, D., Fern\u00e1ndez-Jim\u00e9nez, R., Garc\u00eda-Prieto, J., \u2026 Iba\u00f1ez, B. (2016). Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension. Basic Research in Cardiology, 111(4), 49. https:\/\/doi.org\/10.1007\/s00395-016-0567-0 .","DOI":"10.1007\/s00395-016-0567-0"},{"key":"9819_CR13","doi-asserted-by":"publisher","unstructured":"Belge, C., Hammond, J., Dubois-Deruy, E., Manoury, B., Hamelet, J., Beauloye, C., \u2026 Balligand, J.-L. (2014). Enhanced expression of \u03b23-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase. Circulation, 129(4), 451\u201362. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.004940 .","DOI":"10.1161\/CIRCULATIONAHA.113.004940"},{"issue":"5","key":"9819_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/1756287215591763","volume":"7","author":"M Vij","year":"2015","unstructured":"Vij, M., & Drake, M. J. (2015). Clinical use of the \u03b23 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome. Therapeutic Advances in Urology, 7(5), 241\u2013248. https:\/\/doi.org\/10.1177\/1756287215591763 .","journal-title":"Therapeutic Advances in Urology"},{"issue":"8","key":"9819_CR15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/CIRCULATIONAHA.116.022829","volume":"134","author":"X Rossello","year":"2016","unstructured":"Rossello, X., & Yellon, D. M. (2016). Cardioprotection: the disconnect between bench and bedside. Circulation, 134(8), 574\u2013575. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022829 .","journal-title":"Circulation"},{"key":"9819_CR16","doi-asserted-by":"publisher","unstructured":"Eltink, C., Lee, J., Schaddelee, M., Zhang, W., Kerbusch, V., Meijer, J., \u2026 Sawamoto, T. (2012). Single dose pharmacokinetics and absolute bioavailability of mirabegron, a \u03b23-adrenoceptor agonist for treatment of overactive bladder. International Journal of Clinical Pharmacology and Therapeutics, 50(11), 838\u201350. https:\/\/doi.org\/10.5414\/CP201782 .","DOI":"10.5414\/CP201782"},{"key":"9819_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.vascn.2017.04.008","volume":"87","author":"C Korstanje","year":"2017","unstructured":"Korstanje, C., Suzuki, M., Yuno, K., Sato, S., Ukai, M., Schneidkraut, M. J., & Yan, G. X. (2017). Translational science approach for assessment of cardiovascular effects and proarrhythmogenic potential of the beta-3 adrenergic agonist mirabegron. Journal of Pharmacological and Toxicological Methods, 87, 74\u201381. https:\/\/doi.org\/10.1016\/j.vascn.2017.04.008 .","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"9819_CR18","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Jim\u00e9nez, R., S\u00e1nchez-Gonz\u00e1lez, J., Ag\u00fcero, J., Garc\u00eda-Prieto, J., L\u00f3pez-Mart\u00edn, G. J., Garc\u00eda-Ruiz, J. M., \u2026 Ib\u00e1\u00f1ez, B. (2015). Myocardial edema after ischemia\/reperfusion is not stable and follows a bimodal pattern. Journal of the American College of Cardiology, 65(4), 315\u2013323. https:\/\/doi.org\/10.1016\/j.jacc.2014.11.004 .","DOI":"10.1016\/j.jacc.2014.11.004"},{"issue":"5","key":"9819_CR19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2527\/jas1973.365927x","volume":"36","author":"KW Kelley","year":"1973","unstructured":"Kelley, K. W., Curtis, S. E., Marzan, G. T., Karara, H. M., & Anderson, C. R. (1973). Body surface area of female swine. Journal of Animal Science, 36(5), 927\u2013930.","journal-title":"Journal of Animal Science"},{"key":"9819_CR20","doi-asserted-by":"publisher","unstructured":"Bundgaard, H., Axelsson, A., Hartvig Thomsen, J., S\u00f8rgaard, M., Kofoed, K. F., Hasselbalch, R., \u2026 Rasmussen, H. H. (2017). The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial. European Journal of Heart Failure, 19(4), 566\u2013575. https:\/\/doi.org\/10.1002\/ejhf.714 .","DOI":"10.1002\/ejhf.714"},{"issue":"3","key":"9819_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s11897-011-0064-6","volume":"8","author":"C Gauthier","year":"2011","unstructured":"Gauthier, C., Rozec, B., Manoury, B., & Balligand, J.-L. (2011). Beta-3 adrenoceptors as new therapeutic targets for cardiovascular pathologies. Current Heart Failure Reports, 8(3), 184\u2013192. https:\/\/doi.org\/10.1007\/s11897-011-0064-6 .","journal-title":"Current Heart Failure Reports"},{"key":"9819_CR22","doi-asserted-by":"publisher","unstructured":"Takasu, T., Ukai, M., Sato, S., Matsui, T., Nagase, I., Maruyama, T., \u2026 Yamaguchi, O. (2007). Effect of (R)-2-(2-aminothiazol-4-yl)-4\u2032-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function. The Journal of Pharmacology and Experimental Therapeutics, 321(2), 642\u20137. https:\/\/doi.org\/10.1124\/jpet.106.115840","DOI":"10.1124\/jpet.106.115840"},{"issue":"6","key":"9819_CR23","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.eururo.2012.08.056","volume":"62","author":"N Aizawa","year":"2012","unstructured":"Aizawa, N., Homma, Y., & Igawa, Y. (2012). Effects of mirabegron, a novel \u03b23-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin. European Urology, 62(6), 1165\u20131173. https:\/\/doi.org\/10.1016\/j.eururo.2012.08.056 .","journal-title":"European Urology"},{"issue":"2b","key":"9819_CR24","doi-asserted-by":"publisher","first-page":"E132","DOI":"10.1111\/j.1464-410X.2012.11240.x","volume":"110","author":"JI Gillespie","year":"2012","unstructured":"Gillespie, J. I., Palea, S., Guilloteau, V., Guerard, M., Lluel, P., & Korstanje, C. (2012). Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the \u03b23-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction. BJU International, 110(2b), E132\u2013E142. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11240.x .","journal-title":"BJU International"},{"key":"9819_CR25","doi-asserted-by":"crossref","unstructured":"Gauthier, C., Tavernier, G., Trochu, J. N., Leblais, V., Laurent, K., Langin, D., \u2026 Le Marec, H. (1999). Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists. The Journal of Pharmacology and Experimental Therapeutics, 290(2), 687\u201393.","DOI":"10.1016\/S0022-3565(24)34951-1"},{"issue":"3","key":"9819_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/1074248415604462","volume":"21","author":"X Rossello","year":"2015","unstructured":"Rossello, X., Hall, A. R., Bell, R. M., & Yellon, D. M. (2015). Characterization of the Langendorff perfused isolated mouse heart model of global ischemia-reperfusion injury: impact of ischemia and reperfusion length on infarct size and LDH release. Journal of Cardiovascular Pharmacology and Therapeutics, 21(3), 286\u2013295. https:\/\/doi.org\/10.1177\/1074248415604462 .","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"8","key":"9819_CR27","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/CIRCRESAHA.118.312784","volume":"122","author":"P Kleinbongard","year":"2018","unstructured":"Kleinbongard, P., Amanakis, G., Skyschally, A., & Heusch, G. (2018). Reflection of cardioprotection by remote ischemic perconditioning in attenuated ST-segment elevation during ongoing coronary occlusion in pigs: evidence for cardioprotection from ischemic injury. Circulation Research, 122(8), 1102\u20131108. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312784 .","journal-title":"Circulation Research"},{"issue":"8","key":"9819_CR28","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/CIRCRESAHA.118.312939","volume":"122","author":"X Rossello","year":"2018","unstructured":"Rossello, X., & Ibanez, B. (2018). Infarct size reduction by targeting ischemic injury. Circulation Research, 122(8), 1041\u20131043.","journal-title":"Circulation Research"},{"key":"9819_CR29","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Ruiz, J. M., Fern\u00e1ndez-Jim\u00e9nez, R., Garc\u00eda-Alvarez, A., Pizarro, G., Gal\u00e1n-Arriola, C., Fern\u00e1ndez-Friera, L., \u2026 Ib\u00e1\u00f1ez, B. (2016). Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function. Journal of the American College of Cardiology, 67(18), 2093\u20132104. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.050 .","DOI":"10.1016\/j.jacc.2016.02.050"},{"issue":"13","key":"9819_CR30","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/heartjnl-2015-308980","volume":"102","author":"K Pryds","year":"2016","unstructured":"Pryds, K., Terkelsen, C. J., Sloth, A. D., Munk, K., Nielsen, S. S., Schmidt, M. R., & B\u00f8tker, H. E. (2016). Remote ischaemic conditioning and healthcare system delay in patients with ST-segment elevation myocardial infarction. Heart, 102(13), 1023\u20131028. https:\/\/doi.org\/10.1136\/heartjnl-2015-308980 .","journal-title":"Heart"},{"key":"9819_CR31","doi-asserted-by":"publisher","unstructured":"Dall\u2019Armellina, E., Karia, N., Lindsay, A. C., Karamitsos, T. D., Ferreira, V., Robson, M. D., \u2026 Choudhury, R. P. (2011). Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circulation. Cardiovascular Imaging, 4(3), 228\u201336. https:\/\/doi.org\/10.1161\/CIRCIMAGING.111.963421 .","DOI":"10.1161\/CIRCIMAGING.111.963421"},{"key":"9819_CR32","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Jim\u00e9nez, R., Gal\u00e1n-Arriola, C., S\u00e1nchez-Gonz\u00e1lez, J., Ag\u00fcero, J., L\u00f3pez-Mart\u00edn, G. J., Gomez-Talavera, S., \u2026 Ibanez, B. (2017). Effect of ischemia duration and protective interventions on the temporal dynamics of tissue composition after myocardial infarction. Circulation Research, 121(4), 439\u2013450. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310901 .","DOI":"10.1161\/CIRCRESAHA.117.310901"},{"key":"9819_CR33","doi-asserted-by":"publisher","unstructured":"Jablonowski, R., Engblom, H., Kanski, M., Nordlund, D., Koul, S., van der Pals, J., \u2026 Arheden, H. (2015). Contrast-enhanced CMR overestimates early myocardial infarct size: mechanistic insights using ECV measurements on day 1 and day 7. JACC Cardiovascular Imaging, 8(12), 1379\u20131389. https:\/\/doi.org\/10.1016\/j.jcmg.2015.08.015 .","DOI":"10.1016\/j.jcmg.2015.08.015"},{"key":"9819_CR34","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Jim\u00e9nez, R., Garc\u00eda-Prieto, J., S\u00e1nchez-Gonz\u00e1lez, J., Ag\u00fcero, J., L\u00f3pez-Mart\u00edn, G. J., Gal\u00e1n-Arriola, C., \u2026 Ib\u00e1\u00f1ez, B. (2015). Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia\/reperfusion. Journal of the American College of Cardiology, 66(7), 816\u201328. https:\/\/doi.org\/10.1016\/j.jacc.2015.06.023 .","DOI":"10.1016\/j.jacc.2015.06.023"},{"key":"9819_CR35","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Jim\u00e9nez, R., Barreiro-P\u00e9rez, M., Martin-Garc\u00eda, A., S\u00e1nchez-Gonz\u00e1lez, J., Ag\u00fcero, J., Gal\u00e1n-Arriola, C., \u2026 Ibanez, B. (2017). Dynamic edematous response of the human heart to myocardial infarction: implications for assessing myocardial area at risk and salvage. Circulation, 136(14), 1288\u20131300. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.025582 .","DOI":"10.1161\/CIRCULATIONAHA.116.025582"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12265-018-9819-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-018-9819-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-018-9819-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T05:29:50Z","timestamp":1751779790000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12265-018-9819-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["9819"],"URL":"https:\/\/doi.org\/10.1007\/s12265-018-9819-8","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"type":"print","value":"1937-5387"},{"type":"electronic","value":"1937-5395"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"16 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Ibanez and Dr. Garc\u00eda-\u00c1lvarez are inventors of the patent entitled \u201cUse of selective beta-3 adrenergic agonists for the treatment of pulmonary hypertension\u201d (PCT\/ES2013\/070611). Javier S\u00e1nchez-Gonz\u00e1lez is Philips employee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"No human studies were carried out by the authors for this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Subjects"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Studies"}}]}}